Clinical trial
Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast…
NCT00075413 · The University of Texas Medical Branch, Galveston, Other · Withdrawn
Key facts
| NCT number | NCT00075413 |
|---|---|
| Title | Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer |
| Official title | A Pilot Phase II Protocol Of Arsenic Trioxide (TRISENOX) In Subjects With Advanced Carcinoma Of The Breast |
| Lead sponsor | The University of Texas Medical Branch, Galveston, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | arsenic trioxide |
| Enrollment | 0 |
| Start date | Nov 1, 2002 |
| Primary completion | Jul 1, 2005 |
| First posted | Jan 12, 2004 |
| Last update posted | Oct 2, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: